Cargando…

Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19

We describe the case of a 65-year-old male who presented to an outside hospital for shortness of breath, nausea and vomiting 8 days after testing positive for COVID-19. Initial workup revealed massive bilateral pulmonary emboli and thrombocytopenia. The patient was then admitted to our hospital, rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Katherine, Bucher, Donald, Jain, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149303/
https://www.ncbi.nlm.nih.gov/pubmed/34031097
http://dx.doi.org/10.1136/bcr-2021-243315
_version_ 1783697936455041024
author Julian, Katherine
Bucher, Donald
Jain, Rohit
author_facet Julian, Katherine
Bucher, Donald
Jain, Rohit
author_sort Julian, Katherine
collection PubMed
description We describe the case of a 65-year-old male who presented to an outside hospital for shortness of breath, nausea and vomiting 8 days after testing positive for COVID-19. Initial workup revealed massive bilateral pulmonary emboli and thrombocytopenia. The patient was then admitted to our hospital, received an inferior vena cava filter and initially started on argatroban for autoimmune heparin-induced thrombocytopenia (HIT) prophylaxis. On hospital stay day 6, labs revealed a diagnosis of HIT in the setting of COVID-19. This case highlights the rare occurrence of a patient developing HIT without heparin exposure and in the setting of a novel infectious agent, COVID-19.
format Online
Article
Text
id pubmed-8149303
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81493032021-06-09 Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19 Julian, Katherine Bucher, Donald Jain, Rohit BMJ Case Rep Case Report We describe the case of a 65-year-old male who presented to an outside hospital for shortness of breath, nausea and vomiting 8 days after testing positive for COVID-19. Initial workup revealed massive bilateral pulmonary emboli and thrombocytopenia. The patient was then admitted to our hospital, received an inferior vena cava filter and initially started on argatroban for autoimmune heparin-induced thrombocytopenia (HIT) prophylaxis. On hospital stay day 6, labs revealed a diagnosis of HIT in the setting of COVID-19. This case highlights the rare occurrence of a patient developing HIT without heparin exposure and in the setting of a novel infectious agent, COVID-19. BMJ Publishing Group 2021-05-24 /pmc/articles/PMC8149303/ /pubmed/34031097 http://dx.doi.org/10.1136/bcr-2021-243315 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
spellingShingle Case Report
Julian, Katherine
Bucher, Donald
Jain, Rohit
Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title_full Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title_fullStr Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title_full_unstemmed Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title_short Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19
title_sort autoimmune heparin-induced thrombocytopenia: a rare manifestation of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149303/
https://www.ncbi.nlm.nih.gov/pubmed/34031097
http://dx.doi.org/10.1136/bcr-2021-243315
work_keys_str_mv AT juliankatherine autoimmuneheparininducedthrombocytopeniaararemanifestationofcovid19
AT bucherdonald autoimmuneheparininducedthrombocytopeniaararemanifestationofcovid19
AT jainrohit autoimmuneheparininducedthrombocytopeniaararemanifestationofcovid19